BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31673653)

  • 1. Gross Tumor Delineation in Esophageal Cancer on MRI Compared With
    Vollenbrock SE; Nowee ME; Voncken FEM; Kotte ANTJ; Goense L; van Rossum PSN; van Lier ALHMW; Heijmink SW; Bartels-Rutten A; Wessels FJ; Aleman BMP; Dewit L; Kerkmeijer LGW; Jansen EPM; Intven M; Lips IM; Meijer GJ; Nijkamp J
    Adv Radiat Oncol; 2019; 4(4):596-604. PubMed ID: 31673653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geometrical Comparison and Quantitative Evaluation of
    Li H; Li J; Li F; Zhang Y; Li Y; Guo Y; Xu L
    Front Oncol; 2021; 11():772428. PubMed ID: 35004291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.
    Nowee ME; Voncken FEM; Kotte ANTJ; Goense L; van Rossum PSN; van Lier ALHMW; Heijmink SW; Aleman BMP; Nijkamp J; Meijer GJ; Lips IM;
    Clin Transl Radiat Oncol; 2019 Jan; 14():33-39. PubMed ID: 30519647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
    Han K; Croke J; Foltz W; Metser U; Xie J; Shek T; Driscoll B; Ménard C; Vines D; Coolens C; Simeonov A; Beiki-Ardakani A; Leung E; Levin W; Fyles A; Milosevic MF
    Radiother Oncol; 2016 Sep; 120(3):519-525. PubMed ID: 27528120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented
    Schakel T; Peltenburg B; Dankbaar JW; Cardenas CE; Aristophanous M; Terhaard CHJ; Hoogduin JM; Philippens MEP
    Phys Imaging Radiat Oncol; 2018 Jan; 5():13-18. PubMed ID: 33458363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
    Bundschuh RA; Andratschke N; Dinges J; Duma MN; Astner ST; Brügel M; Ziegler SI; Molls M; Schwaiger M; Essler M
    Strahlenther Onkol; 2012 Jul; 188(7):592-8. PubMed ID: 22441441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography.
    Rusten E; Rekstad BL; Undseth C; Al-Haidari G; Hanekamp B; Hernes E; Hellebust TP; Malinen E; Guren MG
    Radiat Oncol; 2017 Sep; 12(1):147. PubMed ID: 28874205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.
    Lai AYT; Perucho JAU; Xu X; Hui ES; Lee EYP
    BMC Cancer; 2017 Dec; 17(1):825. PubMed ID: 29207964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
    Dalah E; Moraru I; Paulson E; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
    Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
    Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
    Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
    Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver Variability in the Delineation of Gross Tumour Volume and Specified Organs-at-risk During IMRT for Head and Neck Cancers and the Impact of FDG-PET/CT on Such Variability at the Primary Site.
    Gudi S; Ghosh-Laskar S; Agarwal JP; Chaudhari S; Rangarajan V; Nojin Paul S; Upreti R; Murthy V; Budrukkar A; Gupta T
    J Med Imaging Radiat Sci; 2017 Jun; 48(2):184-192. PubMed ID: 31047367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using
    Borggreve AS; Goense L; van Rossum PSN; Heethuis SE; van Hillegersberg R; Lagendijk JJW; Lam MGEH; van Lier ALHMW; Mook S; Ruurda JP; van Vulpen M; Voncken FEM; Aleman BMP; Bartels-Rutten A; Ma J; Fang P; Musall BC; Lin SH; Meijer GJ
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):998-1009. PubMed ID: 31987972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI.
    Hearn N; Bugg W; Chan A; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
    Br J Radiol; 2020 Oct; 93(1114):20200543. PubMed ID: 32877210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
    Bird D; Scarsbrook AF; Sykes J; Ramasamy S; Subesinghe M; Carey B; Wilson DJ; Roberts N; McDermott G; Karakaya E; Bayman E; Sen M; Speight R; Prestwich RJ
    BMC Cancer; 2015 Nov; 15():844. PubMed ID: 26530182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gross tumour volume delineation in anal cancer on T2-weighted and diffusion-weighted MRI - Reproducibility between radiologists and radiation oncologists and impact of reader experience level and DWI image quality.
    Min LA; Vacher YJL; Dewit L; Donker M; Sofia C; van Triest B; Bos P; van Griethuysen JJW; Maas M; Beets-Tan RGH; Lambregts DMJ
    Radiother Oncol; 2020 Sep; 150():81-88. PubMed ID: 32540336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-PET, and MR Images of Head and Neck Cancer.
    Anderson CM; Sun W; Buatti JM; Maley JE; Policeni B; Mott SL; Bayouth JE
    Jacobs J Radiat Oncol; 2014 Sep; 1(1):006. PubMed ID: 25568889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.